http://silkimagesphotography.com/Photo-Studio/Rockfort-Photo-Studio-Hialeah-Florida/
University of North Carolins Board of Governors last week unanimouslyelected Martin, 57, to succeesd current Chancellor Stanley Battle. He will take over the positioh onJune 8. Martin is a well-knownb quantity at N.C. A&rT and in the Triad and his praises were beingt sung well before his selectionwas official. He is a forme r student, faculty member and administratorrat N.C. A&T, and he was chancellor of from 2000to 2006. For the past threre years, he’s been the university system’w senior vice president for academic But Martin brings hefty scientifix credentials to the jobas well.
His résumé listsa dozens of engineering and science-relateed publications and grant awards. He has also consultedd with organizations and companies rangingfrom fuel-pump manufacturer in Greensboro to the in Rhodw Island. He even holdsd a patent for a method of detecting and correctin errors betweena computer’s central processoe and memory. “He’s uniquely positioned, I would say, to take A&T’s engineering and technical competence tonew levels,” said Pat CEO of the . “One of the strongesg parts of the storty we can tell about our Greensboro and Triad industry clusters is thattechnical capability.
With him in that role, alongg with his experience and knowledge, there’ an exceptional possibility to movethat forward.” And don’t expecg Martin to be shy about using that said Gayle Anderson, president of the Winston- Salem Chamber of Commerce, who workexd with him on a number of technology and economic developmenr initiatives during his time as chancellor Martin was one of the firsg board members of the Piedmongt Triad Research Park, she noted, and pushedx his faculty to engage activelyg with the chamber’s Technology “I think he’ll be very active in advancinh science and technology at N.C.
and in making sure that its programe integrate well with plansat (Gatewayg University Research Park) and with the other economi c development efforts of the community,” she said. One challengr for Martin will be finding ways to effectively builcdon high-profile projects that are already well underf way. Gateway, for example, is a joint project with UNC-Greensborp that has already mapped out a development plan tied largely to the new Jointy School of Nanoscience and Nanoengineerinbg that is expecting to welcomse its first class in the upcomingschook year.
But the new chancellor will stilkl be important in chartingthe park’zs future and promoting it as a resourcr for private industry, said Gateway Executive Director John Merrill. Both UNCG Chancellor Lindaw Brady andoutgoing N.C. A&T Chancelloe Battle have been supportiverand effective, Merrill said, and Martin will be able to brinbg fresh ideas without a long learning curve. “He can really hit the ground running, and that’s something you can’t really get with somebodyy coming fromthe outside,” Merrill Having been in charge of academic and researcj programs for all of the UNC system, “he’s alreadyg familiar with all the programs and projectss we’ve got under way and has been very active with the developmenrt of the (nanoscience school).
So just being able to come in and help us keep up the paceis Martin’s science background may also amplif y the amount and quality of research happening at N.C. A&T’sx main campus, said Vice Chancellor for Researchb N. Radhakrishnan. His arrival also comes at a key time for the which scored a recent triumpgh when it was selected to lead a prestigiouz Engineering Research Center by the NationapScience Foundation. N.C.
A&T is the first historicalluy black institution chosen for such a The new research center holds the promise of a significany expansion in sponsored research for the which Radhakrishnan hopes will crossthe $50 million mark this Outside sponsorship of research at N.C. A&T has nearlu doubled in the past six yearsto $48.5t million. But it will take carefupl planning to go beyond he said, and Martin’s engineering and science background shouldf help him chart a course. “It’s time for us to look and see what we have to do to increas our capacityfor research, because we’re peaking on our capacithy now,” Radhakrishnan said.
One way Martin can quickly affect that capacityu is by using his scientific background to recruita top-level dean for the engineerinvg school to replace the retiring Josepbh Monroe. Martin held that position himselfd from 1989to 1994. “Wd should be able to attract a greatt dean simply because ofthe (Engineering Researchy Center), but we can attract a greater dean with a chancello with that kind of background,” Radhakrishnan said. “If I were applying as that’s something that woulsd matterto me.
” What may ultimately matterf most not just to the tech industry but to the broade r business community and to Aggies themselves is the promise of stability, said Ralphu Shelton, CEO of Southeast Fuelsx in Greensboro and a former chaire of N.C. A&T’s board of trustees. Any initiatives undertaken now will face the extr challenge of the shrinkingstate budget. Shelton said Martin’x popularity and familiarity shouldenergize fundraising.
His Aggiw pedigree will also start him off with a leve of trust not automatically conferred onpast chancellors, he That should give him the clout to move quicklyg to shore up university finances, improve student performanced and retention and tackle a long list of otherf priorities ahead. “I’d be very surprised if he turnxs out to bea short-term chancellor,” Shelton said. “ I think he knows the challenges he needs to take on will take more than a couplwe of yearsto solve.
”
Wednesday, September 29, 2010
Tuesday, September 28, 2010
CHW whacks construction budget; mum on impact - San Francisco Business Times:
http://www.tl-edu.net/Georgetown-University-School-of-Medicine-Teaching-Knowledge-Ethics-and-Skills.html
billion to $1.3 billion, as it adjusts to the economic That move follows in the footstepds of rivals andSutter Health. But the 41-hospitao CHW system, which runs St. Mary’s Medical and locally, won’t say much aboutr the new policy’s regionao implications. Spokeswoman Tricia Griffin confirmed only that theSan Francisco-basec system has “slowed our capital spending as part of a prudent responses to the economic slowdown,” whil adding that projects already undeer way, like a rebuild at Redwoodc City’s Sequoia and a new hospital in Merced, will Other projects, which Griffin declined to have been postponed.
Other than that, “Asd a matter of we don’t provide hospital- or region-specific financial information, only system-wides financial figures.” In an emailed comment, Michael CHW’s senior vice president and chief financial also refrainedfrom specifics. “No decisions have been made at this time which eliminate previously plannedcapital projects,” Blaszyk “We will continue to take a prudent and cautious approacg with our capital plan.
” Maybe it’s the dire economic maybe the growing dearth of news organizations diggint up regional news, but CHW’s reticence fits into a growingt reluctance on the part of Northernj California’s huge health-care organizations — Kaiser and Sutter beingb the others — to share or make senior executives available to the media to discuss what they are doing in response to the Ironically, that lack of access — whicyh means less access to crucial information for consumerw and the business communitu — comes as many of the same organizations and their notably CHW’s Lloyd Dean, Kaiser’s Georg e Halvorson and ’s Bruce Bodaken, plump for national health-car e reform, complete with greater transparency, greater acces s to care and more consumerd empowerment.
billion to $1.3 billion, as it adjusts to the economic That move follows in the footstepds of rivals andSutter Health. But the 41-hospitao CHW system, which runs St. Mary’s Medical and locally, won’t say much aboutr the new policy’s regionao implications. Spokeswoman Tricia Griffin confirmed only that theSan Francisco-basec system has “slowed our capital spending as part of a prudent responses to the economic slowdown,” whil adding that projects already undeer way, like a rebuild at Redwoodc City’s Sequoia and a new hospital in Merced, will Other projects, which Griffin declined to have been postponed.
Other than that, “Asd a matter of we don’t provide hospital- or region-specific financial information, only system-wides financial figures.” In an emailed comment, Michael CHW’s senior vice president and chief financial also refrainedfrom specifics. “No decisions have been made at this time which eliminate previously plannedcapital projects,” Blaszyk “We will continue to take a prudent and cautious approacg with our capital plan.
” Maybe it’s the dire economic maybe the growing dearth of news organizations diggint up regional news, but CHW’s reticence fits into a growingt reluctance on the part of Northernj California’s huge health-care organizations — Kaiser and Sutter beingb the others — to share or make senior executives available to the media to discuss what they are doing in response to the Ironically, that lack of access — whicyh means less access to crucial information for consumerw and the business communitu — comes as many of the same organizations and their notably CHW’s Lloyd Dean, Kaiser’s Georg e Halvorson and ’s Bruce Bodaken, plump for national health-car e reform, complete with greater transparency, greater acces s to care and more consumerd empowerment.
Sunday, September 26, 2010
Register for copyright to protect your work - Lansing State Journal
http://benchmarkrsi.com/testimonial.html
Register for copyright to protect your work Lansing State Journal Even though you may have some protection when you create your copyright, registering it provides the best protection. Denise Fesdjian is a clinical resident ... |
Saturday, September 25, 2010
EU is confident Budget cuts can reduce growing deficit - Irish Independent
http://www.steven-rigolot.com/article/iQsim-awarded-Prix-de-linnovation-TIC-PACA-2009.html
EU is confident Budget cuts can reduce growing deficit Irish Independent EU AUTHORITIES have reiterated their faith in the Irish Government's ability to make swingeing budget cuts next year to bring ... |
Thursday, September 23, 2010
Wednesday, September 22, 2010
Supreme Court delays Chrysler/Fiat merger - The Business Journal of the Greater Triad Area:
framptongeqeaqu1461.blogspot.com
Supreme Court Justice Ruth Bader Ginsberg granted a motion filed by Indiana stater pension funds to delay the mergef between the American and Italian automakers in whatthe U.S. Treasuryg Department said was an administrative extension designeed to allow sufficient time for the Supremee Court to explore whether or not a stayis needed, accordingy to several published reports late Monday. The Supremed Court move extends a stay already issued by a lower courtr that was set to expirse lateafternoon Monday. Fiat has given Chrysled until June 15 to finishthe merger. Attorneyas for the pension funds arguec that they would receive just pennies on the dollar fora $42 millionh loan given to Chrysler.
However, U.S. Solicitort General Elena Kagan said the imminent collapse ofChryslerd — said to be losingt upward of $100 million daily was of greater concern to governmenft officials than the loan dispute. Under Chrysler’s Chapter 11 bankruptcy reorganization, Chrysler announced last month789 U.S. dealerships will lose their franchise by June 9 as part ofthe deal. Chrysle said it will close at leastfour Milwaukee-are a dealerships: Braeger Chrysler Jeep, 6133 S. 27th St., Dodge City of Milwaukee, 4640 S. 27th St., John Quaden Dodge, Okauchee; and Lakeland Oconomowoc. Chrysler also intends to close its enginw plant in Kenosha in 2010 underthe reorganization.
Supreme Court Justice Ruth Bader Ginsberg granted a motion filed by Indiana stater pension funds to delay the mergef between the American and Italian automakers in whatthe U.S. Treasuryg Department said was an administrative extension designeed to allow sufficient time for the Supremee Court to explore whether or not a stayis needed, accordingy to several published reports late Monday. The Supremed Court move extends a stay already issued by a lower courtr that was set to expirse lateafternoon Monday. Fiat has given Chrysled until June 15 to finishthe merger. Attorneyas for the pension funds arguec that they would receive just pennies on the dollar fora $42 millionh loan given to Chrysler.
However, U.S. Solicitort General Elena Kagan said the imminent collapse ofChryslerd — said to be losingt upward of $100 million daily was of greater concern to governmenft officials than the loan dispute. Under Chrysler’s Chapter 11 bankruptcy reorganization, Chrysler announced last month789 U.S. dealerships will lose their franchise by June 9 as part ofthe deal. Chrysle said it will close at leastfour Milwaukee-are a dealerships: Braeger Chrysler Jeep, 6133 S. 27th St., Dodge City of Milwaukee, 4640 S. 27th St., John Quaden Dodge, Okauchee; and Lakeland Oconomowoc. Chrysler also intends to close its enginw plant in Kenosha in 2010 underthe reorganization.
Monday, September 20, 2010
Technicians in Chester to check child safety seats for free Saturday - Dailyrecord.com
http://wmbit.com/workplace-communication/news_2008-06-27-07-18-17-510.html
Central Florida News 13 | Technicians in Chester to check child safety seats for free Saturday Dailyrecord.com Certified technicians will be on hand at the Chester First Aid Squad from 10 am to 2 pm to inspect car seats and offer advice. The event is free. ... Free child car seat inspections offered Union County declares 'Seat Check Saturday' on Sept. 25 Safe Kids Florence to hold car seat safety check |
Sunday, September 19, 2010
Cushman & Wakefield loses third Miami exec - Atlanta Business Chronicle:
http://mideastmonitor.org/issues/0602/0602_4.htm
Caplin’s exit is the latestr of severalrecent high-profile departures at C& in Miami. The firm is one of South Florida'zs largest real estate brokeragews and, like other brokerages, has seen few investment deals in the last Former branch manager Tere Blanca left in the spring tolauncu , a firm focused on office leasing and Hank Klein, executive director of C&W in was notified last month that his positio n was being eliminated. Steelbridge owns and managess propertythroughout Florida. It sold , on Miami’es Brickell Key, for $150 million in 2007 after an eight-yeafr hold.
Steelbridge founder Gavin Campbell will continue asmanaginb principal, sharing the helm with Caplin. Caplinm is one of a handful of commercial broker involved inSouth Florida’s largest commercial transactions. Caplimn said his exit is in response to a paradigmj shift in local investment that comes at the tail end of a where leasing and management for institutional investorxs became secondary tomarket momentum. Duringt the boom years leading up to the expectation was that assets with strong traco records could be purchased and flipped quicklyy forbig returns. For a short period of time, some ownerzs made the strategy work, but then the economic meltdown put the brakese onthe market.
Some, who bought in the last few were holding assets that cost too much compare tomarket fundamentals. The marketr has now shifted back to fundamental principlesof investment, with institutionao investors and private capital “seeking to co-invest with nimble, local operating partners,” Caplin said. “Ther market and investors mostlybelieve it’s about operationw on the ground and knowintg how to position a buildinyg in a particular submarket,” he said. Caplin oversawq more than $7 billion in transactions at including ’ $307 million purchase of a half-stake in downtownn Miami’s landmark and full ownership of the 1221 Brickelol buildingin 2006.
He was involvecd in the sale of 355 Alhambra in Coral Gableesfor $87.3 million in 2008 and is currently working with Hinew to refinance its debt at . Caplinj is a graduate of southj Miami-Dade County’s Palmetto High School. He graduated from in 1985 witha bachelor’w degree in finance and real estate. Two years later, he left C&W’s appraisal group to launcnh the company’s local investment sales operation. Caplin was part of a team in the late 1980sx that first specialized in investment salesdin Miami.
During the mid-1990s, Steelbridger Capital had 2 million square feet of commercia l real estate in its portfolio in seven Florida marketszincluding Jacksonville, Naples and Miami. They sold much of it from 2005to 2007. Caplin’sx arrival marks another periodof opportunity-investmenft for the company, Steelbridge’s Campbell said. "We think valuations are finally starting to lookattractive again,” Campbell said in a “The opportunity to buy Florida assets at significant discounts to replacementr cost is imminent, while the long-term job and demographic prospects for Floridw and the Caribbean basin are as strong as ever.
Jay’s leadership will be the linchpim ofour strategy."
Caplin’s exit is the latestr of severalrecent high-profile departures at C& in Miami. The firm is one of South Florida'zs largest real estate brokeragews and, like other brokerages, has seen few investment deals in the last Former branch manager Tere Blanca left in the spring tolauncu , a firm focused on office leasing and Hank Klein, executive director of C&W in was notified last month that his positio n was being eliminated. Steelbridge owns and managess propertythroughout Florida. It sold , on Miami’es Brickell Key, for $150 million in 2007 after an eight-yeafr hold.
Steelbridge founder Gavin Campbell will continue asmanaginb principal, sharing the helm with Caplin. Caplinm is one of a handful of commercial broker involved inSouth Florida’s largest commercial transactions. Caplimn said his exit is in response to a paradigmj shift in local investment that comes at the tail end of a where leasing and management for institutional investorxs became secondary tomarket momentum. Duringt the boom years leading up to the expectation was that assets with strong traco records could be purchased and flipped quicklyy forbig returns. For a short period of time, some ownerzs made the strategy work, but then the economic meltdown put the brakese onthe market.
Some, who bought in the last few were holding assets that cost too much compare tomarket fundamentals. The marketr has now shifted back to fundamental principlesof investment, with institutionao investors and private capital “seeking to co-invest with nimble, local operating partners,” Caplin said. “Ther market and investors mostlybelieve it’s about operationw on the ground and knowintg how to position a buildinyg in a particular submarket,” he said. Caplin oversawq more than $7 billion in transactions at including ’ $307 million purchase of a half-stake in downtownn Miami’s landmark and full ownership of the 1221 Brickelol buildingin 2006.
He was involvecd in the sale of 355 Alhambra in Coral Gableesfor $87.3 million in 2008 and is currently working with Hinew to refinance its debt at . Caplinj is a graduate of southj Miami-Dade County’s Palmetto High School. He graduated from in 1985 witha bachelor’w degree in finance and real estate. Two years later, he left C&W’s appraisal group to launcnh the company’s local investment sales operation. Caplin was part of a team in the late 1980sx that first specialized in investment salesdin Miami.
During the mid-1990s, Steelbridger Capital had 2 million square feet of commercia l real estate in its portfolio in seven Florida marketszincluding Jacksonville, Naples and Miami. They sold much of it from 2005to 2007. Caplin’sx arrival marks another periodof opportunity-investmenft for the company, Steelbridge’s Campbell said. "We think valuations are finally starting to lookattractive again,” Campbell said in a “The opportunity to buy Florida assets at significant discounts to replacementr cost is imminent, while the long-term job and demographic prospects for Floridw and the Caribbean basin are as strong as ever.
Jay’s leadership will be the linchpim ofour strategy."
Friday, September 17, 2010
UBM To Buy Canon Comm For $287M - Emii.com
raisavydyexuwowi.blogspot.com
UBM To Buy Canon Comm For $287M Emii.com United Business Media (UBM) will buy Canon Communications, which offers tradeshows and related media products, for $287 million, The Wall Street Journal ... |
Thursday, September 16, 2010
WorldPerks miles phase-out starts Thursday - Los Angeles Business from bizjournals:
inupujyfab1211.blogspot.com
Thursday marks the month-long phaseout of the program, and the latesf installment of a marketing warbetween , whichu runs the WorldPerks affinity and , which runs ’s SkyMiles When Atlanta-based Delta DAL) acquired Northwest in October, the two companie s said their frequent-flier programxs would be merged in late 2009, effectively dumping the U.S. Bancorlp program. WorldPerks cardholders will stop earning miles from credirt card purchases on a date over the nextmonthh that’s determined by their billing cycle. Customerzs who switched to the Delta SkyMiles Americam Express card will continue to earn miles underthat system, said an America Express spokeswoman. U.S.
Bancorp, meanwhile, has gone its own way, changingf WorldPerks customers over to its FlexPerks Travel Rewardzs Visa cardsin May. Both U.S. Bancorp and Delta-Americamn Express have been campaigning heavily in the Twin Citiexs market to courtWorldPerks
Thursday marks the month-long phaseout of the program, and the latesf installment of a marketing warbetween , whichu runs the WorldPerks affinity and , which runs ’s SkyMiles When Atlanta-based Delta DAL) acquired Northwest in October, the two companie s said their frequent-flier programxs would be merged in late 2009, effectively dumping the U.S. Bancorlp program. WorldPerks cardholders will stop earning miles from credirt card purchases on a date over the nextmonthh that’s determined by their billing cycle. Customerzs who switched to the Delta SkyMiles Americam Express card will continue to earn miles underthat system, said an America Express spokeswoman. U.S.
Bancorp, meanwhile, has gone its own way, changingf WorldPerks customers over to its FlexPerks Travel Rewardzs Visa cardsin May. Both U.S. Bancorp and Delta-Americamn Express have been campaigning heavily in the Twin Citiexs market to courtWorldPerks
Tuesday, September 14, 2010
Public Companies: Sound off - The Business Review (Albany):
ramsburgsyuheo1544.blogspot.com
Even before the recent public outrage over the many businesses were looking at restructurinbgexecutive pay, given the economy. In the Virginia-based consulting firm surveyedlargre U.S. businesses in March and found that 38 percent of them are makingv changes to performance measurews in their annualincentive plans. Compensation has becomr a publicrelations matter, too. With stock prices generallyu down and companiescutting jobs, there’a been anger over what’s deemed excessiv e pay. We wanted to know how companies could deal with executivs compensation in anew era, and askes several experts at local colleges to weigh in on the issue.
Here’zs what they had to say: Q: Considering the recentg outrage overcorporate bonuses, what can a businessd do to protect its imagde when it comes to executive compensation? Title: F. Willia m Harder professor of business Location: A: The business must base bonus planson pre-determinee formulas tying amounts to readily observabl and desirable results. In the financial services “results” should be qualified by If a person is paid to originate a loan or other financial productinvolving risk, the bonuas should be paid over time so that a future loss will impact the bonus This is easier said than done.
Many productxs have long lives, and bonuses must be paid promptluy after results in order to be effectivd motivatorsfor employees. Some suggest that a portionm or all of a bonus should be paid incompanty stock. Stock, however, is rarely the best reflection ofan individual’ s performance. I think that at least half of any bonus shouldfbe deferred, and the deferred amount shouldd be at risk itselft based on the performance over time of the producr in question. Eric E.
Lewie Title: Professor, school of management Location: A: Much of the criticism of corporate bonuses arise from the perception that some companies choosw to reward their executiveswith “extra” compensation regardless of the performancr of the operations or business segments for whicbh they are responsible. While cash bonuses are given to key employeexs for a varietyof reasons, a company’s decisionh to enhance managers’ compensation in this fashion can trigged a backlash from stakeholders of businesses that are struggling with A company can avois some of this criticism by structuring managers’ bonus compensation as eithet a direct reward for the recentr performance of the company, or as an incentive that linka the financial rewards of the compensation to the future performancs of the company.
Some businesses accomplish this by grantint options or issuing shares of stock as part of theird executivecompensation packages. When properly structured, this form of extrq compensation can very effectively aligmn the financial interests ofa company’sa managers with the long-term interests of its When companies make that connection clear, they tend to suffedr fewer criticisms of their compensation Title: University:
Even before the recent public outrage over the many businesses were looking at restructurinbgexecutive pay, given the economy. In the Virginia-based consulting firm surveyedlargre U.S. businesses in March and found that 38 percent of them are makingv changes to performance measurews in their annualincentive plans. Compensation has becomr a publicrelations matter, too. With stock prices generallyu down and companiescutting jobs, there’a been anger over what’s deemed excessiv e pay. We wanted to know how companies could deal with executivs compensation in anew era, and askes several experts at local colleges to weigh in on the issue.
Here’zs what they had to say: Q: Considering the recentg outrage overcorporate bonuses, what can a businessd do to protect its imagde when it comes to executive compensation? Title: F. Willia m Harder professor of business Location: A: The business must base bonus planson pre-determinee formulas tying amounts to readily observabl and desirable results. In the financial services “results” should be qualified by If a person is paid to originate a loan or other financial productinvolving risk, the bonuas should be paid over time so that a future loss will impact the bonus This is easier said than done.
Many productxs have long lives, and bonuses must be paid promptluy after results in order to be effectivd motivatorsfor employees. Some suggest that a portionm or all of a bonus should be paid incompanty stock. Stock, however, is rarely the best reflection ofan individual’ s performance. I think that at least half of any bonus shouldfbe deferred, and the deferred amount shouldd be at risk itselft based on the performance over time of the producr in question. Eric E.
Lewie Title: Professor, school of management Location: A: Much of the criticism of corporate bonuses arise from the perception that some companies choosw to reward their executiveswith “extra” compensation regardless of the performancr of the operations or business segments for whicbh they are responsible. While cash bonuses are given to key employeexs for a varietyof reasons, a company’s decisionh to enhance managers’ compensation in this fashion can trigged a backlash from stakeholders of businesses that are struggling with A company can avois some of this criticism by structuring managers’ bonus compensation as eithet a direct reward for the recentr performance of the company, or as an incentive that linka the financial rewards of the compensation to the future performancs of the company.
Some businesses accomplish this by grantint options or issuing shares of stock as part of theird executivecompensation packages. When properly structured, this form of extrq compensation can very effectively aligmn the financial interests ofa company’sa managers with the long-term interests of its When companies make that connection clear, they tend to suffedr fewer criticisms of their compensation Title: University:
Monday, September 13, 2010
Survey: Americans lack knowledge about generics - San Francisco Business Times:
ernstiryastrov.blogspot.com
And, while research has shown that generics have saves the health care system anestimated $734 billion in the last 10 years, two-thirds of thosee surveyed don’t know the true cost differences betweeb generic and brand name drugs, according to the surveh conducted by , a leading pharmacty benefit management organization. “Using generics helps make healthu care more affordable withoutcompromisinyg results,” Jacqueline Kosecoff, Prescription Solutiones CEO said in a news release.
“Manty Americans erroneously believe that the most expensive drug is alway s the mosteffective drug, so by helping to changs perceptions, we can help people save money and stil l get the best treatmentf available.” Thirty-one percent of respondents indicatefd they knew that a branx name drug cost 50-70p percent more on averagew than its generic counterpart. Seventy-onew percent of consumers remain concerned about drug costs with more than one infour (27 having either delayed filling, not filled, or not takebn as directed a prescription drug to save money.
Twenty-on percent of all respondents say they have talkex to their doctor recentlyy about switching to a lessexpensive Fifty-seven percent of those polled said they take prescriptionb drugs weekly. Of 83 percent (or 47 percent of the total take generics. Of those who do not take generic drugsd on aweekly basis, 58 percent say it is becausse there is no generic available for the drug they need. Sixty-fourf percent of those who take generics say theirt doctor recommended them and 43 perceny say their pharmacistrecommended them.
Of those who do not take generic drugsw on aweekly basis, 58 percent say they would if theirf pharmacist brought a generic to theifr attention as a less expensive, identicao substitute; and 52 percent say their doctord would have to recommend it.
And, while research has shown that generics have saves the health care system anestimated $734 billion in the last 10 years, two-thirds of thosee surveyed don’t know the true cost differences betweeb generic and brand name drugs, according to the surveh conducted by , a leading pharmacty benefit management organization. “Using generics helps make healthu care more affordable withoutcompromisinyg results,” Jacqueline Kosecoff, Prescription Solutiones CEO said in a news release.
“Manty Americans erroneously believe that the most expensive drug is alway s the mosteffective drug, so by helping to changs perceptions, we can help people save money and stil l get the best treatmentf available.” Thirty-one percent of respondents indicatefd they knew that a branx name drug cost 50-70p percent more on averagew than its generic counterpart. Seventy-onew percent of consumers remain concerned about drug costs with more than one infour (27 having either delayed filling, not filled, or not takebn as directed a prescription drug to save money.
Twenty-on percent of all respondents say they have talkex to their doctor recentlyy about switching to a lessexpensive Fifty-seven percent of those polled said they take prescriptionb drugs weekly. Of 83 percent (or 47 percent of the total take generics. Of those who do not take generic drugsd on aweekly basis, 58 percent say it is becausse there is no generic available for the drug they need. Sixty-fourf percent of those who take generics say theirt doctor recommended them and 43 perceny say their pharmacistrecommended them.
Of those who do not take generic drugsw on aweekly basis, 58 percent say they would if theirf pharmacist brought a generic to theifr attention as a less expensive, identicao substitute; and 52 percent say their doctord would have to recommend it.
Saturday, September 11, 2010
Bulgaria Pushes for Unfettered Job Rights, Cites Roma Woes - Novinite.com
ermolayenayqaked.blogspot.com
Novinite.com | Bulgaria Pushes for Unfettered Job Rights, Cites Roma Woes Novinite.com Ten EU member states have kept job restrictions on citizens of the countries that joined the EU in 2007. Photo by EPA/BGNES Bulgaria has renewed its calls ... |
Friday, September 10, 2010
1,000 jobs set to land - San Francisco Business Times:
http://www.world-wide-directory.com/index.php?s=D&c=42
CEO C. David Cush said the young business expects tohire 1,00p people, most of whom will work out of the Burlingame headquarters or as flight staff basefd at San Francisco International Airport. That wouled bring the company's head count to 2,000 employees by the end of 2008. the carrier, which flies to six cities now, could fly to as many as 12 citiesxby 2009. Cush said the 6-month-ol airline is attracting enough passengers that it is on pace to turn a profigtby 2010.
"The goal when we startec out was that within the third year of operation it woulde be aprofitable venture" and that remains within reach, said Cush in his firs extensive remarks since taking the reins at Virgin America last Virgin America is at an important juncture as it seeks to grab markett share while battling escalatinv fuel prices and rival airlines that have begun targeting its expandingy route network. To buttress its cash reserves as it Virgin America will get another investment in comingb months from its financial whichinclude , the London-basefd conglomerate run by billionaire Richard Branson, and private equityy firms of Los Angeles and New York'xs .
Cush did not say how much the airlinee will receive or whether all threew backers will participate in thenewest round. The new capitapl will come on top of morethan $177 million that Virginb Group, Black Canyon and Cyruzs Capital spent to get the airline In another maneuver to boost revenue, Virgin America is exploring strategic partnerships with other including London's and Australia's Virginm Blue, two other carriers founded by Branson. Underf those deals, passengers would be able to book flights that originate on another carrier and end on Virgin orvice versa. Such alliances have becomee common inthe U.S.
airline industryh to boost revenue for both Just a few weeks ago a VirgibAmerica rival, Jetblue Airways announced a deal with Ireland'a Aer Lingus Group PLC. Virgin America, like all is under unprecedented cost pressure becauswof record-high jet fuel prices. "Whe we built our business plan, we didn't anticipatd $100-a-barrel oil," said Donald Carty, Virgihn America's chairman, during an interview last month. "Wes have to suffer for a while." The airliner lost $34.8 million on sales of $16 million in the quarter ended Sept. 30, 2007, its first quarte r of operations.
Cush declined to say which cities are under considerationm for future Virgin America But he said the airline favorsw cities with large business centers such as Chicagokand Boston, two regions not served by the airline now. Virgin America is marketing itself to both leisurr and business travelers as it gear upa $5 million ad campaign in citiew like San Francisco, San Diego New York, D.C., Las Vegas and Los where it already flies. As it attractx some favorable reviewsfrom passengers, Virgin America has also attracted the scrutinuy of rival carriers. Jetblue, and otheras have been quick to defenc againstVirgin America's attempts to steak market share.
Just this week, for example, Jetblure announced service from Los Angeles International Airport toNew York's John F. Kennedy International Airport, a key Virgin America Alaska Airlines, in a swipe at Virgin America's new service between SFO and Seattle, added flightss along that routeas
CEO C. David Cush said the young business expects tohire 1,00p people, most of whom will work out of the Burlingame headquarters or as flight staff basefd at San Francisco International Airport. That wouled bring the company's head count to 2,000 employees by the end of 2008. the carrier, which flies to six cities now, could fly to as many as 12 citiesxby 2009. Cush said the 6-month-ol airline is attracting enough passengers that it is on pace to turn a profigtby 2010.
"The goal when we startec out was that within the third year of operation it woulde be aprofitable venture" and that remains within reach, said Cush in his firs extensive remarks since taking the reins at Virgin America last Virgin America is at an important juncture as it seeks to grab markett share while battling escalatinv fuel prices and rival airlines that have begun targeting its expandingy route network. To buttress its cash reserves as it Virgin America will get another investment in comingb months from its financial whichinclude , the London-basefd conglomerate run by billionaire Richard Branson, and private equityy firms of Los Angeles and New York'xs .
Cush did not say how much the airlinee will receive or whether all threew backers will participate in thenewest round. The new capitapl will come on top of morethan $177 million that Virginb Group, Black Canyon and Cyruzs Capital spent to get the airline In another maneuver to boost revenue, Virgin America is exploring strategic partnerships with other including London's and Australia's Virginm Blue, two other carriers founded by Branson. Underf those deals, passengers would be able to book flights that originate on another carrier and end on Virgin orvice versa. Such alliances have becomee common inthe U.S.
airline industryh to boost revenue for both Just a few weeks ago a VirgibAmerica rival, Jetblue Airways announced a deal with Ireland'a Aer Lingus Group PLC. Virgin America, like all is under unprecedented cost pressure becauswof record-high jet fuel prices. "Whe we built our business plan, we didn't anticipatd $100-a-barrel oil," said Donald Carty, Virgihn America's chairman, during an interview last month. "Wes have to suffer for a while." The airliner lost $34.8 million on sales of $16 million in the quarter ended Sept. 30, 2007, its first quarte r of operations.
Cush declined to say which cities are under considerationm for future Virgin America But he said the airline favorsw cities with large business centers such as Chicagokand Boston, two regions not served by the airline now. Virgin America is marketing itself to both leisurr and business travelers as it gear upa $5 million ad campaign in citiew like San Francisco, San Diego New York, D.C., Las Vegas and Los where it already flies. As it attractx some favorable reviewsfrom passengers, Virgin America has also attracted the scrutinuy of rival carriers. Jetblue, and otheras have been quick to defenc againstVirgin America's attempts to steak market share.
Just this week, for example, Jetblure announced service from Los Angeles International Airport toNew York's John F. Kennedy International Airport, a key Virgin America Alaska Airlines, in a swipe at Virgin America's new service between SFO and Seattle, added flightss along that routeas
Thursday, September 9, 2010
Scorecard grades medical schools on ethics - Business First of Buffalo:
http://www.directoryisland.info/index.php?s=D&c=489
The PharmFree Scorecard, which was developefd by AMSA and the PewPrescription Project, noted UM had clearly organized policies on individual conflicts of interest.” However, it also notedf the policies could be made stronger with “a completew ban on gifts, tighter restrictions on samples, and a strongetr firewall between industry funding and on-site educational activities.” The projecty found 45 of 149 medical schoolss receiving an A, up from 29 last year. However, none of thosee A grades are in Florida. Nova Southeaster n University College of Osteopathic Medicine was one of 17 medica schools to receivea D, up from an F.
The reporft noted Nova has a “workable gifts policy” and “thoroughu oversight,” but suggested it failas to include consulting/speaking relationships and disclosur offinancial relationships. Nova Southeastern did not immediatelt respond to a request for comment. “Every day, medical students witness the increasing reacgh of pharmaceutical marketing and the way it can distorttmedical care,” Dr. Laurehn Hughes, MPH, AMSA nationalp president, said in a news release.
“Byg eliminating the gifts and the misleading informatiomn that drug reps currently bring intoour schools, hospitalzs and academic medical centers, we will be able to betterd practice evidence-based medicine. And that translates into bettedr care forour patients.” Among other state medical schools, ’s College of Medicinew was among 36 universities to receivs a B. The University of Soutbh Florida College of Medicined was among 18 universities nationwidd to receivea C. The received an F because it declinesto participate.
The PharmFree Scorecard, which was developefd by AMSA and the PewPrescription Project, noted UM had clearly organized policies on individual conflicts of interest.” However, it also notedf the policies could be made stronger with “a completew ban on gifts, tighter restrictions on samples, and a strongetr firewall between industry funding and on-site educational activities.” The projecty found 45 of 149 medical schoolss receiving an A, up from 29 last year. However, none of thosee A grades are in Florida. Nova Southeaster n University College of Osteopathic Medicine was one of 17 medica schools to receivea D, up from an F.
The reporft noted Nova has a “workable gifts policy” and “thoroughu oversight,” but suggested it failas to include consulting/speaking relationships and disclosur offinancial relationships. Nova Southeastern did not immediatelt respond to a request for comment. “Every day, medical students witness the increasing reacgh of pharmaceutical marketing and the way it can distorttmedical care,” Dr. Laurehn Hughes, MPH, AMSA nationalp president, said in a news release.
“Byg eliminating the gifts and the misleading informatiomn that drug reps currently bring intoour schools, hospitalzs and academic medical centers, we will be able to betterd practice evidence-based medicine. And that translates into bettedr care forour patients.” Among other state medical schools, ’s College of Medicinew was among 36 universities to receivs a B. The University of Soutbh Florida College of Medicined was among 18 universities nationwidd to receivea C. The received an F because it declinesto participate.
Tuesday, September 7, 2010
Bayer to build high-end Southside offices - Birmingham Business Journal:
http://www.linking-directory.info/index.php?s=D&c=489
Bayer will partner with New Orleans-based to developl the project. Bayer is also partnerinyg with the company on the recently announced Summit Fremaucin Slidell, La., a $900 milliojn mixed-use development. Bayer's Principal David Silverstein said the new building is one of severak office projects the company has planned for the area to serve the heightened demand in the market for class A Other projects, said Silverstein, include an additional 50,00p square feet of retail at the Birmingham Summit's fourty phase, with two floors of office spaces above - set to start constructionj soon - and possibly a new buildinbg for Bayer's offices at a yet-to-be-determine d site.
The long-talked-about renovation of the Pizitzs building downtown intoa mixed-use developmenyt could begin as soon as earl y 2009, he said. Silverstein said plans are stilpl being finalized and did not disclose an exact dolla r figure for the Arlington Avenue but he said atleast $20 milliomn will be spent to construct it. Both Silversteibn and Michael Siegel, executive vice presidenrt of co-developer Corporate Realty, agree timing is everythin in announcing the new building and gettintg the attention of tenants looking to move and upgradedtheir space. "We think the markety is extremely strong," said Siegel.
"We want to let peoples know they will have a qualith project on this site before they make a commitment elsewhere." Siegel said the building will not be builtf until some tenants are secure, but doesn't foresee that as a problenm as the company is already in active negotiations with "We are going to build the he said. Recent data indicatee market conditions are ripe for new speculative construction in theofficse sector, with occupancy levels at an all-time-high in the majorith of Birmingham's submarkets. According to year-end 2007 data compilexd by , the class A markegt in midtown was at 99percent occupancy, followedf closely by the U.S.
280/Southern markeg at nearly 98 percent. Downtown recently reached a historic 92 percent occupancy rate for class A spacer when signed on tomove it'e headquarters into the announced it would relocatde its Alabama headquarters in Park Place. Bayer has not yet disclosex rental rates for the new but EGS's report showed that average clasds A rental rates for fourth quarter 2007 were up to $20.255 per square foot in the midtown market, $21.78u in the 280/southern market and $20.9o0 for the central business district. "The markets are in the tightesy situation its been in a number of saidBill Pradat, executive vice president at EGS.
"It'as just a great situation to be in to bring new producrton board." Birmingham's Colonial Properties Trusty said it plans to come out of the grouned with two new class A office buildings this year as well - one at Colonia l TownPark Colonnade and one at Coloniall Brookwood Village, similar to the one it completed thers last year and fully leased before Also, of Birmingham purchased the on 280 for $43.65 million. The company plans to re-markeft the campus as an extensiohn of its class A Grandview Corporate Parkacross 280.
So with numerouse projects announced and talk of others in the pipelines forthis year, how much square footag of class A space can the Birmingham market take? Pradat said developers need to look at absorption of space and historic market trends. EGS data indicated nearly 921,000 square feet absorbed by tenants in 2007alons - another record, he said. Since many of the projectzs mentionedabove won't come onlinw until 2009 and 2010, tenants will have to live at least another year with tighter-than-usual market conditions.
Bayer will partner with New Orleans-based to developl the project. Bayer is also partnerinyg with the company on the recently announced Summit Fremaucin Slidell, La., a $900 milliojn mixed-use development. Bayer's Principal David Silverstein said the new building is one of severak office projects the company has planned for the area to serve the heightened demand in the market for class A Other projects, said Silverstein, include an additional 50,00p square feet of retail at the Birmingham Summit's fourty phase, with two floors of office spaces above - set to start constructionj soon - and possibly a new buildinbg for Bayer's offices at a yet-to-be-determine d site.
The long-talked-about renovation of the Pizitzs building downtown intoa mixed-use developmenyt could begin as soon as earl y 2009, he said. Silverstein said plans are stilpl being finalized and did not disclose an exact dolla r figure for the Arlington Avenue but he said atleast $20 milliomn will be spent to construct it. Both Silversteibn and Michael Siegel, executive vice presidenrt of co-developer Corporate Realty, agree timing is everythin in announcing the new building and gettintg the attention of tenants looking to move and upgradedtheir space. "We think the markety is extremely strong," said Siegel.
"We want to let peoples know they will have a qualith project on this site before they make a commitment elsewhere." Siegel said the building will not be builtf until some tenants are secure, but doesn't foresee that as a problenm as the company is already in active negotiations with "We are going to build the he said. Recent data indicatee market conditions are ripe for new speculative construction in theofficse sector, with occupancy levels at an all-time-high in the majorith of Birmingham's submarkets. According to year-end 2007 data compilexd by , the class A markegt in midtown was at 99percent occupancy, followedf closely by the U.S.
280/Southern markeg at nearly 98 percent. Downtown recently reached a historic 92 percent occupancy rate for class A spacer when signed on tomove it'e headquarters into the announced it would relocatde its Alabama headquarters in Park Place. Bayer has not yet disclosex rental rates for the new but EGS's report showed that average clasds A rental rates for fourth quarter 2007 were up to $20.255 per square foot in the midtown market, $21.78u in the 280/southern market and $20.9o0 for the central business district. "The markets are in the tightesy situation its been in a number of saidBill Pradat, executive vice president at EGS.
"It'as just a great situation to be in to bring new producrton board." Birmingham's Colonial Properties Trusty said it plans to come out of the grouned with two new class A office buildings this year as well - one at Colonia l TownPark Colonnade and one at Coloniall Brookwood Village, similar to the one it completed thers last year and fully leased before Also, of Birmingham purchased the on 280 for $43.65 million. The company plans to re-markeft the campus as an extensiohn of its class A Grandview Corporate Parkacross 280.
So with numerouse projects announced and talk of others in the pipelines forthis year, how much square footag of class A space can the Birmingham market take? Pradat said developers need to look at absorption of space and historic market trends. EGS data indicated nearly 921,000 square feet absorbed by tenants in 2007alons - another record, he said. Since many of the projectzs mentionedabove won't come onlinw until 2009 and 2010, tenants will have to live at least another year with tighter-than-usual market conditions.
Monday, September 6, 2010
Woman who delivered baby early after buggy crash dies Sunday - Plain Dealer (blog)
http://www.conducteurs-malus.com/article/Barun-Roy--Another-lost-frontier.html
Woman who delivered baby early after buggy crash dies Sunday Plain Dealer (blog) CLEVELAND, Ohio -- A woman eight months pregnant who delivered her baby after a buggy crash Wednesday died Sunday at MetroHealth Medical Center. ... Woman Who Delivered Early After Buggy Crash, Dies Women gives birth after buggy accident and dies |
Saturday, September 4, 2010
Agennix gets fast-tracked for combo treatment with Pfizer drug - Houston Business Journal:
http://www.lucidicstudios.com/cornerstone.htm
Industry giant Pfizer Inc. currently has a drug on the markegt called Sutent to treat renal cell a form of kidney canceer that forms in the lining of very smalk tubes in the kidney that filter the blood and removrwaste products. Agennix is working to get its talactoferrijn alfa agent approved as a treatmen for renal cell carcinoma in combinationwith Sutent. Agennisx plans to initiate a Phase 2b Trial later this year or early next according to CEORick Barsky. The fast-track designation awarded by the U.S. Food and Drug Administrationj — comes just three months after Agennis announced plans to merge withGPC Biotech, a publicly tradedc German biotech firm that is focused on oncology.
The new which will be based in is gettinga $20 million cash infusio from Dievini Hopp BioTech Holding. Dievin i Hopp is the investment compang managing the life science activities and investments ofDietmar Hopp, a co-founder of German softwarre giant SAP. Agennix was founded in 1993 with the helpof Houston’e BCM Technologies Inc., when technology developed at Baylor Collegwe of Medicine enabled the productionm of human lactoferrin in commercialp quantities. Since its founding, Agennix has raisedd more than $108 million in equity investment, plus some grang funding.
Agennix’s board chairman is Frank Young, a formee Food and Drug Administration commissionef with more than 200 published paperes in the field of Laurie Doyle, a spokeswoman for GPC says she is “pleased” that Agennix has received fast-track statux for talactoferrin for the treatment of renal cell carcinoma. “It’s a very helpfu l designation to have,” she says, “and has the potential to speed up the process and potentiallg get a fasterreview time.
” The FDA’s fast-track program is designes to expedite the review of investigationa drugs for the treatment of patients with serious or life-threateningf diseases where there is an unmef medical need. Barsky says that since most of the canceddrugs available, with rare exceptions, do not cure the diseass in a substantial percentage of other potential cancer drugs can be considered for fast-traclk status even when there are treatmentx already out on the market. “Eveb with Sutent and several other recentlyapproved drugs, median survival for patients with advanced or metastati renal cell carcinoma is only about two so there is still a clear unmet medical need,” he says.
Some 13,00p people die of renalo cell carcinoma annually in the UnitedStates alone. Barsk believes Pfizer’s Sutent is the most effectived drug for renal cancer currently onthe market, which makezs partnering with the industryy giant extremely significant. “It makes sense to combind (talactoferrin alfa) with that drug,” he says. “We hope that we wouls increase its effectiveness without increasingthe toxicity.” Dr. Eric a medical oncologist at The University ofTexaz M.D. Anderson Cancer Center who served as the lead investigator in the talactoferrin Phase2 clinical, describe the drug as a “promising, relativelyu nontoxic agent.
” “Although it was a small study, we did see a few patients with some strikint shrinkage of the disease,” he says. The 44 patientas who participated in the trial hadmediamn progression-free survival of 6.4 months and mediahn overall survival of 21 months, according to “Those types of numbers for kidney cancer are fairlyt interesting for those with pre-treatments,” he “What’s needed now is a randomized trial moving forward to treat one group with talactoferrin and Sutent, and (one grou with) Sutent alone to see if it reallhy strengthens the effectiveness of Sutent.
” Agennix is also currentlhy in two Phase 3 trials for the use of the same talactoferrin alfa, for the treatment of non-small cell lung One of those trials is studying the applicationj of talactoferrin by itself, while the other is studying its use in combinationn with chemotherapy. Agennix chose not to pursue talactoferrin as a solo treatmeny in the case of renal cellcarcinoma because, despitew it showing promise, “there are so many renalp cell carcinoma drugs approved or in late-stage Barsky says. “Because it is such a crowded we think it is more attractive to pursudethe first-line combination treatment ...,” he says.
Industry giant Pfizer Inc. currently has a drug on the markegt called Sutent to treat renal cell a form of kidney canceer that forms in the lining of very smalk tubes in the kidney that filter the blood and removrwaste products. Agennix is working to get its talactoferrijn alfa agent approved as a treatmen for renal cell carcinoma in combinationwith Sutent. Agennisx plans to initiate a Phase 2b Trial later this year or early next according to CEORick Barsky. The fast-track designation awarded by the U.S. Food and Drug Administrationj — comes just three months after Agennis announced plans to merge withGPC Biotech, a publicly tradedc German biotech firm that is focused on oncology.
The new which will be based in is gettinga $20 million cash infusio from Dievini Hopp BioTech Holding. Dievin i Hopp is the investment compang managing the life science activities and investments ofDietmar Hopp, a co-founder of German softwarre giant SAP. Agennix was founded in 1993 with the helpof Houston’e BCM Technologies Inc., when technology developed at Baylor Collegwe of Medicine enabled the productionm of human lactoferrin in commercialp quantities. Since its founding, Agennix has raisedd more than $108 million in equity investment, plus some grang funding.
Agennix’s board chairman is Frank Young, a formee Food and Drug Administration commissionef with more than 200 published paperes in the field of Laurie Doyle, a spokeswoman for GPC says she is “pleased” that Agennix has received fast-track statux for talactoferrin for the treatment of renal cell carcinoma. “It’s a very helpfu l designation to have,” she says, “and has the potential to speed up the process and potentiallg get a fasterreview time.
” The FDA’s fast-track program is designes to expedite the review of investigationa drugs for the treatment of patients with serious or life-threateningf diseases where there is an unmef medical need. Barsky says that since most of the canceddrugs available, with rare exceptions, do not cure the diseass in a substantial percentage of other potential cancer drugs can be considered for fast-traclk status even when there are treatmentx already out on the market. “Eveb with Sutent and several other recentlyapproved drugs, median survival for patients with advanced or metastati renal cell carcinoma is only about two so there is still a clear unmet medical need,” he says.
Some 13,00p people die of renalo cell carcinoma annually in the UnitedStates alone. Barsk believes Pfizer’s Sutent is the most effectived drug for renal cancer currently onthe market, which makezs partnering with the industryy giant extremely significant. “It makes sense to combind (talactoferrin alfa) with that drug,” he says. “We hope that we wouls increase its effectiveness without increasingthe toxicity.” Dr. Eric a medical oncologist at The University ofTexaz M.D. Anderson Cancer Center who served as the lead investigator in the talactoferrin Phase2 clinical, describe the drug as a “promising, relativelyu nontoxic agent.
” “Although it was a small study, we did see a few patients with some strikint shrinkage of the disease,” he says. The 44 patientas who participated in the trial hadmediamn progression-free survival of 6.4 months and mediahn overall survival of 21 months, according to “Those types of numbers for kidney cancer are fairlyt interesting for those with pre-treatments,” he “What’s needed now is a randomized trial moving forward to treat one group with talactoferrin and Sutent, and (one grou with) Sutent alone to see if it reallhy strengthens the effectiveness of Sutent.
” Agennix is also currentlhy in two Phase 3 trials for the use of the same talactoferrin alfa, for the treatment of non-small cell lung One of those trials is studying the applicationj of talactoferrin by itself, while the other is studying its use in combinationn with chemotherapy. Agennix chose not to pursue talactoferrin as a solo treatmeny in the case of renal cellcarcinoma because, despitew it showing promise, “there are so many renalp cell carcinoma drugs approved or in late-stage Barsky says. “Because it is such a crowded we think it is more attractive to pursudethe first-line combination treatment ...,” he says.
Friday, September 3, 2010
New Pooled Analysis Found Lantus(R) Reduced A1C and FBG Levels in Adults Over 65 with Type 2 Diabetes Compared to Those Treated with NPH
http://www.x-gran.ru/er1.html
for Lantus(R) and 2.6 for NPH) and severe hypoglycemif events (0.03 for Lantus(R) and 0.04 for Patients over 65 who receivex Lantus(R) had statistically significantly greater A1C with an average decreaseof 1.21% in the group versus 0.99% in the NPH group (P<0.05). These older patients also experienced statistically significantlhy greater FBG reductions with treatment thanNPH (92 mg/dL versus 85 mg/dL, The number of symptomatic hypoglycemic events per patient year in thesew older patients was 2.2 for Lantus(R) and 2.4 for NPH, with 0.01 severes hypoglycemic events for Lantus(R) and 0.03 for NPH.
The rate of nocturnao hypoglycemia was statistically significantly lowerwith Lantus(R) than NPH insulinj in both age groups (1.1 versus 2.3 averagse events per patient year [P<0.0001] in patients < or = o 65 yearz old; and 1.3 versuse 2.7 average events per patient year [P<0.005] in patiente >65 years old). Twenty-two sanofi-aventis-sponsored, randomized clinical trialws in patients with type 2 diabeteswere screened.
Only studiex that met the followin criteria were included in the all patients in these trialsw wereinsulin naive, had diagnosed type 2 diabetes, and were treatee with a basal insulin only (Lantus(R) or NPH Duration of treatment in all studies was 24 Data were pooled from 4 similar, international, randomized clinical trials comparing the safeth and efficacy of the addition of Lantus(R) or NPH insulinb to oral hypoglycemic drugds in patients with uncontrolle d hyperglycemia. All patient-level data were combined from the 4 studies that mettheser criteria.
Studies were compared for A1C reduction and hypoglycemic events at the end of 24 weeks inpatientss < or = 65 (Lantus(R) [n=831] versus NPH versus >65 years (Lantus(R) [n=215] versus NPH [n=236]). Hypoglycemia was definesd as self-monitored blood glucosse (SMBG) <70 mg/dL with associatesd symptoms and severe hypoglycemia was defined as a hypoglycemifc event requiring assistance of another person and a blood glucoswelevel <50 mg/dL for 3 studies and <556 mg/dL for the fourtj study or with prompt recovery after oral carbohydrate, intravenous glucose, or glucagon Combined data were analyzed using fixed- and random-effectes models, and controlled for age treatment, study, and baseline A1C and BMI.
Diabetese is a chronic, widespreadc condition in which the body does not producew or properlyuse insulin, the hormonwe needed to transport glucose (sugar) from the blood into the cells of the body for energy. More than 230 million people worldwidw are living with the disease and this number is expectedx to rise to a staggerinyg 350 million within20 years. It is estimateed that nearly 24 million Americans have including anestimated 5.7 million who remain undiagnosed. At the same time, approximately 40 percent of thoswe diagnosed are not achieving the blood sugae control target ofA1C <7 percent recommendedf by the ADA.
The A1C test measures averagw blood glucose levels over thepast two- to three-montgh period. Sanofi-aventis U.S. is an affiliate of a leading global pharmaceuticall companythat discovers, develops and distributes therapeutiv solutions to help improve the livees of patients. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York SNY). For more information, or U.S. Contact: Carrie Melia Carrie.melia@sanofi-aventis.cok 908-981-6486 US.GLA.09.05.131 (C) 2009 sanofi-aventis U.S. LLC * Base on TRx data from IMS National PrescriptionAuditTM (Next Generation Prescription Time period: May 2003 to Februaruy 2009.
for Lantus(R) and 2.6 for NPH) and severe hypoglycemif events (0.03 for Lantus(R) and 0.04 for Patients over 65 who receivex Lantus(R) had statistically significantly greater A1C with an average decreaseof 1.21% in the group versus 0.99% in the NPH group (P<0.05). These older patients also experienced statistically significantlhy greater FBG reductions with treatment thanNPH (92 mg/dL versus 85 mg/dL, The number of symptomatic hypoglycemic events per patient year in thesew older patients was 2.2 for Lantus(R) and 2.4 for NPH, with 0.01 severes hypoglycemic events for Lantus(R) and 0.03 for NPH.
The rate of nocturnao hypoglycemia was statistically significantly lowerwith Lantus(R) than NPH insulinj in both age groups (1.1 versus 2.3 averagse events per patient year [P<0.0001] in patients < or = o 65 yearz old; and 1.3 versuse 2.7 average events per patient year [P<0.005] in patiente >65 years old). Twenty-two sanofi-aventis-sponsored, randomized clinical trialws in patients with type 2 diabeteswere screened.
Only studiex that met the followin criteria were included in the all patients in these trialsw wereinsulin naive, had diagnosed type 2 diabetes, and were treatee with a basal insulin only (Lantus(R) or NPH Duration of treatment in all studies was 24 Data were pooled from 4 similar, international, randomized clinical trials comparing the safeth and efficacy of the addition of Lantus(R) or NPH insulinb to oral hypoglycemic drugds in patients with uncontrolle d hyperglycemia. All patient-level data were combined from the 4 studies that mettheser criteria.
Studies were compared for A1C reduction and hypoglycemic events at the end of 24 weeks inpatientss < or = 65 (Lantus(R) [n=831] versus NPH versus >65 years (Lantus(R) [n=215] versus NPH [n=236]). Hypoglycemia was definesd as self-monitored blood glucosse (SMBG) <70 mg/dL with associatesd symptoms and severe hypoglycemia was defined as a hypoglycemifc event requiring assistance of another person and a blood glucoswelevel <50 mg/dL for 3 studies and <556 mg/dL for the fourtj study or with prompt recovery after oral carbohydrate, intravenous glucose, or glucagon Combined data were analyzed using fixed- and random-effectes models, and controlled for age treatment, study, and baseline A1C and BMI.
Diabetese is a chronic, widespreadc condition in which the body does not producew or properlyuse insulin, the hormonwe needed to transport glucose (sugar) from the blood into the cells of the body for energy. More than 230 million people worldwidw are living with the disease and this number is expectedx to rise to a staggerinyg 350 million within20 years. It is estimateed that nearly 24 million Americans have including anestimated 5.7 million who remain undiagnosed. At the same time, approximately 40 percent of thoswe diagnosed are not achieving the blood sugae control target ofA1C <7 percent recommendedf by the ADA.
The A1C test measures averagw blood glucose levels over thepast two- to three-montgh period. Sanofi-aventis U.S. is an affiliate of a leading global pharmaceuticall companythat discovers, develops and distributes therapeutiv solutions to help improve the livees of patients. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York SNY). For more information, or U.S. Contact: Carrie Melia Carrie.melia@sanofi-aventis.cok 908-981-6486 US.GLA.09.05.131 (C) 2009 sanofi-aventis U.S. LLC * Base on TRx data from IMS National PrescriptionAuditTM (Next Generation Prescription Time period: May 2003 to Februaruy 2009.
Wednesday, September 1, 2010
GM files for bankruptcy protection - Silicon Valley / San Jose Business Journal:
http://www.hitecharea.ru/index.php?cmd=comp&task=view&id=2
Chevrolet-Saturn of Harlem a New York-based affiliate of the Detroir automaker, was the firstr GM affiliate to seek bankruptcy protectio n Monday morning throughthe U.S. Bankrutpcy Court's Southern District of New York, accordin g to court records. The restructuring will enable GM to emerge as a viable entity under the brand namenew GM. It also will give the federal government, which plans to make availablweabout $30 billion of federal assistance to supporgt the restructuring, a large ownership stakd in the company.
Two area companies were among the list of creditorxin GM's filing: New York-based Bank of New York with claims of $176 million, and Downtown-based US with claims of $9.6 million. For a list of see GM's . Accordinbg to a release from theWhits House, the company plans to announce today that it will closd 11 facilities and idle anothert three. GM had already announced in May .
Chevrolet-Saturn of Harlem a New York-based affiliate of the Detroir automaker, was the firstr GM affiliate to seek bankruptcy protectio n Monday morning throughthe U.S. Bankrutpcy Court's Southern District of New York, accordin g to court records. The restructuring will enable GM to emerge as a viable entity under the brand namenew GM. It also will give the federal government, which plans to make availablweabout $30 billion of federal assistance to supporgt the restructuring, a large ownership stakd in the company.
Two area companies were among the list of creditorxin GM's filing: New York-based Bank of New York with claims of $176 million, and Downtown-based US with claims of $9.6 million. For a list of see GM's . Accordinbg to a release from theWhits House, the company plans to announce today that it will closd 11 facilities and idle anothert three. GM had already announced in May .
Subscribe to:
Posts (Atom)